Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reinier M van Hest

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Journal of Postgraduate Medicine|December 29, 2006
Population-specific limited sampling strategies for therapeutic drug monitoring of mycophenolic acidReinier M van Hest
Therapeutic Drug Monitoring|July 14, 2017
Pharmacokinetics of Antibiotics in Sub-Saharan African Patient Populations: A Systematic ReviewJeannet C Bos, Reinier M van Hest, Jan M Prins
The Journal of Antimicrobial Chemotherapy|September 3, 2020
Comment on: Effectiveness and safety of an institutional aminoglycoside-based regimen as empirical treatment of patients with pyelonephritisIsabel Spriet, Reinier M van Hest, Willy E Peetermans, et al.
Clinical Pharmacokinetics|September 24, 2005
Population pharmacokinetics of mycophenolic acid in renal transplant recipientsReinier M van Hest, Teun van Gelder, Arnold G Vulto, et al.
BMC Infectious Diseases|April 23, 2017
Antimicrobial prophylaxis outside the operating theatre, an audit in a university hospitalJan W T Deelen, Caroline E Visser, Jan M Prins, et al.
Critical Care Medicine|August 15, 2015
The Area Under the Concentration-Time Curve Is a Better Estimate for Vancomycin Exposure Than Trough LevelsDenise J van Vessem, Nicole P Juffermans, Catherine S C Bouman, et al.
Haematologica|May 7, 2013
A low fixed dose of prothrombin complex concentrate is cost effective in emergency reversal of vitamin K antagonistsNakisa Khorsand, Lisette Giepmans, Karina Meijer, et al.
BMC Infectious Diseases|March 21, 2021
Systematic review: the bioavailability of orally administered antibiotics during the initial phase of a systemic infection in non-ICU patientsAnnemieke K van den Broek, Jan M Prins, Caroline E Visser, et al.
Therapeutic Drug Monitoring|January 19, 2006
Within-patient variability of mycophenolic acid exposure: therapeutic drug monitoring from a clinical point of viewReinier M van Hest, Ron A Mathot, Arnold G Vulto, et al.
Expert Opinion on Drug Metabolism & Toxicology|April 13, 2007
Therapeutic drug monitoring of mycophenolic acid: does it improve patient outcome?Brenda C M de Winter, Ron A A Mathôt, Reinier M van Hest, et al.
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Journal of Postgraduate Medicine|December 29, 2006
Population-specific limited sampling strategies for therapeutic drug monitoring of mycophenolic acidReinier M van Hest
Therapeutic Drug Monitoring|July 14, 2017
Pharmacokinetics of Antibiotics in Sub-Saharan African Patient Populations: A Systematic ReviewJeannet C Bos, Reinier M van Hest, Jan M Prins
The Journal of Antimicrobial Chemotherapy|September 3, 2020
Comment on: Effectiveness and safety of an institutional aminoglycoside-based regimen as empirical treatment of patients with pyelonephritisIsabel Spriet, Reinier M van Hest, Willy E Peetermans, et al.
Clinical Pharmacokinetics|September 24, 2005
Population pharmacokinetics of mycophenolic acid in renal transplant recipientsReinier M van Hest, Teun van Gelder, Arnold G Vulto, et al.
BMC Infectious Diseases|April 23, 2017
Antimicrobial prophylaxis outside the operating theatre, an audit in a university hospitalJan W T Deelen, Caroline E Visser, Jan M Prins, et al.
Critical Care Medicine|August 15, 2015
The Area Under the Concentration-Time Curve Is a Better Estimate for Vancomycin Exposure Than Trough LevelsDenise J van Vessem, Nicole P Juffermans, Catherine S C Bouman, et al.
Haematologica|May 7, 2013
A low fixed dose of prothrombin complex concentrate is cost effective in emergency reversal of vitamin K antagonistsNakisa Khorsand, Lisette Giepmans, Karina Meijer, et al.
BMC Infectious Diseases|March 21, 2021
Systematic review: the bioavailability of orally administered antibiotics during the initial phase of a systemic infection in non-ICU patientsAnnemieke K van den Broek, Jan M Prins, Caroline E Visser, et al.
Therapeutic Drug Monitoring|January 19, 2006
Within-patient variability of mycophenolic acid exposure: therapeutic drug monitoring from a clinical point of viewReinier M van Hest, Ron A Mathot, Arnold G Vulto, et al.
Expert Opinion on Drug Metabolism & Toxicology|April 13, 2007
Therapeutic drug monitoring of mycophenolic acid: does it improve patient outcome?Brenda C M de Winter, Ron A A Mathôt, Reinier M van Hest, et al.
Pageof 9